$1.5m funding for breast cancer project:
This article was originally published in Clinica
An investigation into new ways to detect breast cancer is underway with joint funding of $1.5 million from Hyal Pharmaceutical and the Natural Sciences and Engineering Research Council of Canada. Researchers at McMaster University, the University of Toronto and the Toronto Hospital, will attempt to find out if hyaluronic acid used with MRI in mammography will result in more reliable detection of early-stage breast cancer. Hyaluronic acid binds to breast cancer cells and will be used as a carrier for MRI imaging agents.
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.